Therapeutic Strategies for Huntington's Disease: From the Bench to the Clinic

Publisher： Bentham Science Publishers

E-ISSN： 2211-5579|1|2|137-154

ISSN： 2211-5560

Source： Current Psychopharmacology, Vol.1, Iss.2, 2012-05, pp. : 137-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Strategies for Huntington's Disease: From the Bench to the Clinic

By S. Brocardo Patricia   M. Gil-Mohapel Joana  

Current Psychopharmacology, Vol. 1, Iss. 2, 2012-05 ,pp. : 137-154

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic strategies in Huntington’s disease

By Alberch Jordi   Canals Josep M   Pérez-Navarro Esther  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 4, 2003-04 ,pp. : 449-465

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targets and Therapeutic Strategies in Huntington's Disease

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 361-381

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Therapeutic Antibodies and Derivatives: From the Bench to the Clinic(Guest Editor: Alain Beck)]

By  

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 6, 2008-12 ,pp. : 421-422

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterases as Therapeutic Targets for Huntington’s Disease

By  

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 365-377

Bentham Science Publishers

Access to resources Recommend Favorite